EyePoint (EYPT) Receivables (2011 - 2026)
EyePoint (EYPT) reported Receivables of $1.2 million for Q1 2026, up 161.76% on a YoY basis from $442000.0 in Q1 2025, and up 77.73% sequentially from $651000.0 in Q4 2025.
EyePoint (EYPT) Receivables (2011 - 2026) Analysis & Trends
EyePoint (EYPT) has 16 years of Receivables data on file, last reported at $1.2 million in Q1 2026.
- For the quarter ending Q1 2026, Receivables rose 161.76% year-over-year to $1.2 million; the trailing twelve-month figure through Mar 2026 stood at $1.2 million (up 161.76% YoY), and the FY2025 full-year result was $651000.0, up 7.25% from the prior year.
- Receivables advanced to $1.2 million in Q1 2026, from $651000.0 in the prior quarter.
- In the past five years, Receivables ranged from a high of $22.6 million in Q2 2022 to a low of $378000.0 in Q3 2024.
- A 5-year average of $6.5 million and a median of $1.2 million in 2026 frame the typical range for Receivables.
- Across the five-year window, Receivables plunged 97.69% in 2023 and jumped 176.46% in 2025, its largest moves.
- Tracing EYPT's Receivables over 5 years: stood at $15.5 million in 2022, then slumped by 94.81% to $805000.0 in 2023, then declined by 24.6% to $607000.0 in 2024, then grew by 7.25% to $651000.0 in 2025, then jumped by 77.73% to $1.2 million in 2026.
- Business Quant data shows EYPT's Receivables at $1.2 million in Q1 2026, $651000.0 in Q4 2025, and $1.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 4.97 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 938.02 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 1.13 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.00 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 5.73 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.93 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | EyePoint | 358.61 Mn | 136.07 Mn | 168,000.00 | 1.16 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.16 Mn |
| Dec 31, 2025 | 651,000.00 |
| Sep 30, 2025 | 1.05 Mn |
| Jun 30, 2025 | 625,000.00 |
| Mar 31, 2025 | 442,000.00 |
| Dec 31, 2024 | 607,000.00 |
| Sep 30, 2024 | 378,000.00 |
| Jun 30, 2024 | 1.38 Mn |
| Mar 31, 2024 | 3.02 Mn |
| Dec 31, 2023 | 805,000.00 |
| Sep 30, 2023 | 483,000.00 |
| Jun 30, 2023 | 10.95 Mn |
| Mar 31, 2023 | 10.42 Mn |
| Dec 31, 2022 | 15.50 Mn |
| Sep 30, 2022 | 20.88 Mn |
| Jun 30, 2022 | 22.59 Mn |
| Mar 31, 2022 | 19.59 Mn |
| Dec 31, 2021 | 18.77 Mn |
| Sep 30, 2021 | 13.60 Mn |
| Jun 30, 2021 | 15.11 Mn |